# The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery

> **NCT02381249** · NA · COMPLETED · sponsor: **St. James's Hospital, Ireland** · enrollment: 40 (actual)

## Conditions studied

- Esophageal Neoplasms
- Stomach Neoplasms
- Weight Loss
- Malnutrition
- Pancreatic Neoplasms
- Duodenal Neoplasms

## Interventions

- **DRUG:** Octreotide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02381249
- **Lead sponsor:** St. James's Hospital, Ireland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381249, "The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02381249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*